Healthcare Companies Report Recognitions, Schedules, and Stock Movements - Analyst Notes on WellPoint, Quest Diagnostics, LabCorp, Covance, and Masimo

NEW YORK, April 8, 2014 /PRNewswire/ --

Today, Analysts Review released its analysts' notes regarding WellPoint Inc. (NYSE: WLP), Quest Diagnostics Inc. (NYSE: DGX), Laboratory Corp. of America Holdings (NYSE: LH), Covance Inc. (NYSE: CVD), and Masimo Corporation (NASDAQ: MASI). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.AnalystsReview.com/register

--

WellPoint Inc. Analyst Notes 

On April 1, 2014, WellPoint Inc. (WellPoint) received the Corporate Hispanic Health Leadership Award from the National Hispanic Medical Association (NHMA) for the Company's work in educating the Hispanic community on the Affordable Care Act. According to the release, NHMA has recognized the Company for its proactive efforts in helping to enroll uninsured Hispanics in their communities. Dr. Antonio Linares, Regional Vice President and Medical Director, WellPoint, stated, "It is WellPoint's goal to make sure that Hispanic American families in the communities we serve can control their own health care journey by taking advantage of their many new insurance options, including plans available through the new exchanges. For this reason, we continue our commitment to educate and engage the Hispanic community on the benefits of the law and how to enroll." The full analyst notes on WellPoint Inc. are available to download free of charge at:

http://www.AnalystsReview.com/04082014/WLP/report.pdf

--

Quest Diagnostics Inc. Analyst Notes 

On April 3, 2014, Quest Diagnostics Inc. (Quest Diagnostics) announced that it will report its Q1 2014 financial results on April 24, 2014, before the market opens. The Company will also hold its quarterly conference call to discuss the results on the same day, beginning at 8:30 a.m. The full analyst notes on Quest Diagnostics Inc. are available to download free of charge at:

http://www.AnalystsReview.com/04082014/DGX/report.pdf

--

Laboratory Corp. of America Holdings Analyst Notes 

On April 1, 2014, Laboratory Corp. of America Holdings (LabCorp) announced that its Zero Coupon Convertible Subordinated Notes due 2021 may be converted into cash and Common Stock of LabCorp, if any, subject to the terms of the Zero Coupon Notes and the Indenture, dated as of October 24, 2006, between LabCorp and The Bank of New York Mellon, as trustee (Trustee) and the conversion agent. According to the release, in order to exercise the option to convert all or a portion of the Zero Coupon Notes, holders must validly surrender their Zero Coupon Notes at any time during the calendar quarter through the close of business on June 30, 2014, 5:00 p.m. ET. Additionally, the Company stated that should Zero Coupon Notes be converted, the Company would be required to pay holders in cash for the accreted principal amount of the securities to be converted, with the remaining amount, if any, to be satisfied with shares of Common Stock. The full analyst notes on Laboratory Corp. of America Holdings are available to download free of charge at:

http://www.AnalystsReview.com/04082014/LH/report.pdf

--

Covance Inc. Analyst Notes 

On April 3, 2014, Covance Inc. (Covance) announced that in conjunction with the Company's Q1 2014 financial earnings release, expected to be reported after the market close on May 1, 2014. The Company will host a quarterly investor conference on the following day, May 2, 2014, at 9:00 a.m. ET. Additionally, the Company stated that the event will be archived on its website for 14 days. The full analyst notes on Covance Inc. are available to download free of charge at:

http://www.AnalystsReview.com/04082014/CVD/report.pdf

--

Masimo Corporation Analyst Notes 

On April 3, 2014, Masimo Corporation's (Masimo) stock reflected an increase of 0.58%, at $27.90 per share. For the past three-month trading period, the Company's shares went down by 6.83%, compared to the Nasdaq Composite which went up by 2.56% during the same three-month trading period. The full analyst notes on Masimo Corporation are available to download free of charge at:

http://www.AnalystsReview.com/04082014/MASI/report.pdf

--

About Analysts Review
We provide our members with a simple and reliable way to leverage our economy of scale. Most investors do not have time to track all publicly traded companies, much less perform an in-depth review and analysis of the complexities contained in each situation. That's where Analysts Review comes in. We provide a single unified platform for investors' to hear about what matters. Situation alerts, moving events, and upcoming opportunities.

--

=============

EDITOR NOTES: 

• This is not company news. We are an independent source and our views do not reflect the companies mentioned.
• Information in this release is fact checked and produced on a best efforts basis and reviewed by Nidhi Vatsal, a CFA charterholder. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below.
• This information is submitted as a net-positive to companies mentioned, to increase awareness for mentioned companies to our subscriber base and the investing public.
• If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at pubco [at] AnalystsReview.com.
• For any urgent concerns or inquiries, please contact us at compliance [at] AnalystsReview.com.
• Are you a public company? Would you like to see similar coverage on your company? Send us a full investors' package to research [at] AnalystsReview.com for consideration.

COMPLIANCE PROCEDURE 

Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Analysts Review. An outsourced research services provider represented by Nidhi Vatsal, CFA, has only reviewed the information provided by Analysts Review in this article or report according to the Procedures outlined by Analysts Review. Analysts Review is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.

NOT FINANCIAL ADVICE 

Analysts Review makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.

NO WARRANTY OR LIABILITY ASSUMED 

Analysts Review is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Analysts Review whatsoever for any direct, indirect or consequential loss arising from the use of this document. Analysts Review expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Analysts Review does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

AnalystsReview.com

SOURCE Analysts Review

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

440k+
Newsrooms &
Influencers

9k+
Digital Media
Outlets

270k+
Journalists
Opted In

GET STARTED